Chris La Testa is an experienced technology attorney representing clients in complex civil litigation matters, including intellectual property (patent, trademark, and copyright), pharmaceutical, and products liability disputes.
Mr. La Testa currently serves as Senior Discovery Counsel for Venable's Technology Division, where he is primarily responsible for assisting commercial and intellectual property litigation teams in managing all aspects of discovery through the development of targeted, cost-effective discovery plans. Mr. La Testa counsels corporate clients on e-discovery best practices and processes, advises on privacy and privilege law, and develops and manages legally defensible, cost-effective protocols and guidelines for the collection, processing, review, and production of documents.
Mr. La Testa's recent matters include:
- In re Suboxone Antitrust Litigation – Representation of plaintiff pharmaceutical company in antitrust litigation against manufacturer of opiate addiction treatment Suboxone.
- TAS Energy, Inc. v. Stellar Energy Americas, Inc. – Defense of patent litigations brought by competitor of client relating to systems designed to improve the efficiency of utility-scale power generation facilities. Successful defense of two preliminary injunction motions. Cases settled after positive results obtained from inter partes reviews challenging plaintiff’s asserted claims.
- Automated Video Tech., LLC. V. BlackBerry Corp. et al. – Counsel for defendants in two separate patent infringement cases involving video compression. Obtained dismissal of both cases at close of fact and expert discovery and award of fees and costs. Cases currently on appeal before the Federal Circuit.
- TecSec, Inc. v. International Business Machines Corp., et al. – Representation of defendants in a case alleging infringement of multiple patents related to data encryption and cryptography. Obtained a stipulation of non-infringement of the majority of patents in the case.
- Bavarian Nordic A/S v. Acambis Inc. – Defense of a pharmaceutical company in a Section 337 proceeding before the International Trade Commission regarding patent, trade secret, unfair competition, and tortious conversion claims relating to viral vaccine products. Summary judgment on all claims, involving misappropriation of the virus and unfair competition, before federal district court.
Mr. La Testa is a member of the Board of Directors for the Maryland Volunteer Lawyers for the Arts. Mr. La Testa is also an active member of the American Bar Association's Intellectual Property Law Section, the Maryland State Bar Association (where he has previously served as chair of the Technology Committee for the Young Lawyers Division), and the Bar Association of Baltimore City. Mr. La Testa also commits substantial time to pro bono matters, including assisting clients in tax disputes before the IRS, nonprofit corporate formation, and trademark counseling.